Genzyme Corporation recalls Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, T…
- Recall date
- February 16, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0730-2016
- FDA classification
- Class II
- Brand / firm
- Genzyme Corporation
- Sold / distributed
- Nationwide, Puerto Rico and Malaysia, Taiwan, Brazil, and Israel.
Why it was recalled
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2.
Get recall alerts
Free email alert whenever Genzyme Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Genzyme Corporation